Intramyocardial injections of the continuous erythropoietin receptor activator (CERA) in patients with chronic ischemic cardiomyopathy. Results of the randomized study

Back

HFA Premium Access

Intramyocardial injections of the continuous erythropoietin receptor activator (CERA) in patients with chronic ischemic cardiomyopathy. Results of the randomized study

Session: Rapid Fire 3 - Chronic heart failure management

Topic: Chronic nursing care

Speaker: Mr D. Losik (Dubai, AE)

Event: HEART FAILURE 2016

Congress Presentation

Add to my library

About the speaker

Mr Denis Losik

eMed Support Systems, Dubai (United Arab Emirates)

2 presentations

1 follower

13 more presentations in this session

Morbidity, mortality, and cost impact of stage b and stage c heart failure: comparative analysis to underline the clinical and economic need for heart failure prevention strategy.

Speaker: Doctor S. James (Castlebar, IE)

Access

Abstract

Slides

Effects of 5 years treatment with nebivolol, carvedilol and bisoprolol in heart failure patients

Speaker: Doctor G. Marazzi (Rome, IT)

Access

Abstract

MTP-131, a cardiolipin-targeting peptide, improves mitochondrial activity in the failing human heart

Speaker: Doctor B. Stauffer (Aurora, US)

Access

Abstract

Slides

Is the cohort of paradigm-hf representative of the real world population of patients with systolic heart failure?

Speaker: Doctor G. Rocha Rodrigues (Lisbon, PT)

Access

Abstract

Slides

Evidence-based medications in multi-ethnic Asian patients with heart failure are associated with better outcomes in spite of lower doses

Speaker: Doctor T. Teng (Singapore, SG)

Access

Abstract

Slides

Access the full session

Rapid Fire 3 - Chronic heart failure management

Speakers: Mr D. Losik, Doctor S. James, Doctor G. Marazzi, Doctor B. Stauffer, Doctor G. Rocha Rodrigues...

Access

About the event

HEART FAILURE 2016

21 May - 24 May 2016

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources